A Clinical Study of Dual-Target, Universal CAR-T Cell Therapy for Refractory Systemic Lupus Erythematosus

Clinical trial NCT07444307 · RECRUITING

Trial details

NCT number: NCT07444307
Sponsor: Hangzhou Qihan Biotech Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Systemic Lupus Erythematosus (SLE)

Start date: 2025-12-15
Primary completion: 2028-12-31
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.